25. June 2021 | 14:01 CET
BYD, Siemens Healthineers, Silver Viper: Many trends in one share
Trends and hypes on the stock market are not always easy: Sometimes they are slow, then there are dynamic upward phases, and sometimes you need patience. Whether it is electromobility, renewable energy or the latest developments in medical technology, no one knows when prices will rise. What is certain, however, is that all of the industries mentioned have a future. So how do you invest? We outline three stocks around the mentioned industries.
time to read:
ISIN: BYD CO. LTD H YC 1 | CNE100000296 , SIEMENS HEALTH.AG NA O.N. | DE000SHL1006 , SILVER VIPER MINER. CORP. | CA8283341029
"[...] In our experience, the local communities are supportive and friendly. [...]" Steve Cope, President, CEO and Director, Silver Viper
BYD: These brands are interesting now
Electric car pioneer BYD is considered the darling of investors. There are several reasons for this: The Chinese have their production of batteries and a chip division. The latter products are in short supply worldwide. Some carmakers have even had to temporarily shut down their production lines because of a lack of supplies. BYD is not experiencing this. The Company recently announced that it would raise the prices of its chips from its production by 5% - demand is high and supply is scarce. While other automakers are suffering, BYD is making money.
BYD is also strong in terms of quality and range. In the spring, the Chinese presented a platform that should also enable other manufacturers to realize ranges of over 1,000 km with the help of blade batteries from BYD. German manufacturers usually stop much earlier. The technological progress coupled with the good strategic position speaks for the BYD share. Currently, however, the recovery movement has stalled somewhat. Important marks on the upside are EUR 25 and EUR 28.25 in German trading. If these areas are overcome on a closing price basis and confirmed on the domestic stock exchange, the journey can continue.
Siemens Healthineers: Health as a permanent theme
A trend that has been intact for years and has been given new impetus by the pandemic is the development of increasingly complex medical technology. Hardly any ailment is diagnosed these days without imaging procedures. The extent to which this makes sense is anyone's guess, but the trend among doctors and patients alike is toward wanting to see problems "in black and white." Here is where Siemens Healthineers comes in. Imaging plays an important role for the Company and accounts for more than 60% of its sales. The other divisions are diagnostic devices and therapy forms.
In the meantime, modern medical technology devices are also playing a role in more and more medical practices and are not only found in radiologists' offices. Siemens Healthineers has also done good business with corona tests in recent months. Although many regular examinations were postponed during the pandemic, they have recently been made up. The Company operates in an exciting area and at least offers a slim dividend. The stock has just broken out to a new high. That is usually a buy signal. However, it makes sense to target the stock only if it falls below the EUR 50 mark - after all, the profit is in the purchase.
Silver Viper: Investors show confidence
Investors can also hope for good entry opportunities at Silver Viper. The Company is developing silver projects in Mexico. Silver plays a role in electromobility and medical technology, and there is even silver in solar cells. Therefore, those who cannot decide between the trends mentioned above could therefore consider an investment in a silver company and thus kill several birds with one stone. After all, silver is also a precious metal and interesting in crisis prevention and inflation. Silver Viper primarily operates the La-Virginia project and has recently completed 100 drill holes with a distance of 27,021m. Most recently, the results were incorporated into a resource estimate according to common mining standards. The project thus becomes more quickly understandable even for investors who do not follow the Company closely - this can ensure increased interest on the part of investors.
Also recently, the Company announced a capital measure: CAD 6 million is to flow into the Company. Market participants, including existing shareholders, could purchase the new shares at CAD 0.47. Via warrants, which can be exercised at CAD 0.65, the Company could receive another CAD 8.3 million over the next two years. Thus, the financing seems to be secured. As the share has shown a good development in the past months, the level for the capital increase seems fair. As Silver Viper is valued, as a project developer, at a discount to the resources in the ground, the stock can offer leverage to the silver price. The paper is a possible addition for speculatively oriented investors. Many trends, such as electromobility, solar energy and medical technology, resonate indirectly with Silver Viper.